Carolyn Salter
General Practice · Palestine, TXNPI 1114986395
Payments from drug & device makers
Across 235 payments — averaging $22.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$876
- Boehringer Ingelheim$568
- Novo Nordisk$509
- Lilly USA, LLC$495
- AstraZeneca$481
- Pfizer$339
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,297100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 34 | $876 |
| Boehringer Ingelheim | 22 | $568 |
| Novo Nordisk | 33 | $509 |
| Lilly USA, LLC | 25 | $495 |
| AstraZeneca | 13 | $481 |
| Pfizer | 16 | $339 |
| Otsuka America Pharmaceutical, Inc. | 12 | $261 |
| Dexcom, Inc. | 12 | $223 |
| Mylan Specialty L.p. | 12 | $200 |
| Amarin Pharma, Inc. | 9 | $179 |
| Boston Scientific | 2 | $167 |
| Johnson & Johnson | 3 | $141 |
| Astellas Pharma US Inc | 6 | $107 |
| Biohaven Pharmaceuticals, Inc. | 2 | $86 |
| Medtronic | 1 | $78 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $69 |
| Novartis | 3 | $67 |
| Exact Sciences | 3 | $56 |
| Bayer | 3 | $51 |
| Merck | 3 | $51 |
| Ultragenyx Pharmaceutical Inc. | 2 | $31 |
| Irhythm Technologies, Inc. | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Eisai Inc. | 2 | $24 |
| Seqirus USA Inc | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Abbott | 1 | $18 |
| GSK | 1 | $15 |
| AbbVie | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,297 in reported general payments places this provider in the 95th percentile of 8,074 general practice providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $3,189 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 131 | $3,100 |
| Gabapentin | 28 | $705 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $419 |
| Levothyroxine Sodium | 25 | $378 |
| Atorvastatin Calcium | 28 | $341 |
| Pantoprazole Sodium | 24 | $237 |
| Duloxetine Hcl | 14 | $205 |
| Alprazolam | 46 | $196 |
| Methadone Hcl | 13 | $170 |
| Furosemide | 21 | $161 |
| Sertraline Hcl | 12 | $156 |
| ClopidogrelClopidogrel Bisulfate | 11 | $152 |
| Tamsulosin Hcl | 13 | $144 |
| Metformin Hcl | 13 | $141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $339 | $3,18911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,074 general practice providers in Texas.
Other general practice in Palestine
- Olusoji AfuwapeDallas$12.3M
- Karen CummingsPlano$8.4M
- Helen ShpatsHouston$3.3M
- Kelechi AzuoguHouston$2.5M
- Marcus LastimadoFort Bliss$2.3M
- Christina DeanFrisco$1.9M
- Paul ShrodeMissouri City$1.2M
- Sheila SchmidtPearland$811K
- Danielle CoulterSan Antonio$681K
- Alan DouglasSan Antonio$609K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.